Amdocs Stock Analysis

DOX Stock  USD 89.90  0.52  0.58%   
Amdocs is overvalued with Real Value of 85.6 and Target Price of 108.0. The main objective of Amdocs stock analysis is to determine its intrinsic value, which is an estimate of what Amdocs is worth, separate from its market price. There are two main types of Amdocs' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Amdocs' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Amdocs' stock to identify patterns and trends that may indicate its future price movements.
The Amdocs stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Amdocs is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Amdocs Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Amdocs' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Amdocs Stock Analysis Notes

About 97.0% of the company shares are held by institutions such as insurance companies. The book value of Amdocs was currently reported as 30.56. The company has Price/Earnings To Growth (PEG) ratio of 1.25. Amdocs last dividend was issued on the 27th of March 2024. The entity had 1:4 split on the December 1, 2003. Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. To learn more about Amdocs call Joshua Sheffer at 314 212 7000 or check out https://www.amdocs.com.

Amdocs Quarterly Total Revenue

1.25 Billion

Amdocs Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Amdocs' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Amdocs or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Amdocs Limited Position Reduced by CHURCHILL MANAGEMENT Corp - Defense World

Amdocs Upcoming and Recent Events

Earnings reports are used by Amdocs to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Amdocs previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

Amdocs Largest EPS Surprises

Earnings surprises can significantly impact Amdocs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1999-01-25
1998-12-310.090.10.0111 
1998-11-11
1998-09-300.050.060.0120 
2003-01-22
2002-12-310.180.20.0211 
View All Earnings Estimates

Amdocs Thematic Classifications

In addition to having Amdocs stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Israel Wall Street Idea
Israel Wall Street
Large Israel companies traded on major USA exchanges

Amdocs Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Amdocs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amdocs backward and forwards among themselves. Amdocs' institutional investor refers to the entity that pools money to purchase Amdocs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
American Century Companies Inc2023-12-31
M
Morgan Stanley - Brokerage Accounts2023-12-31
1.7 M
Alliancebernstein L.p.2023-12-31
1.7 M
State Street Corporation2023-12-31
1.6 M
Vanguard Group Inc2023-12-31
1.5 M
Brandes Investment Partners & Co2023-12-31
1.4 M
Norges Bank2023-12-31
1.4 M
Wellington Management Company Llp2023-12-31
1.3 M
Principal Financial Group Inc2023-12-31
1.2 M
Fmr Inc2023-12-31
17.5 M
Hhg Plc2023-12-31
6.5 M
Note, although Amdocs' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Amdocs Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 10.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amdocs's market, we take the total number of its shares issued and multiply it by Amdocs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Amdocs Profitablity

Amdocs' profitability indicators refer to fundamental financial ratios that showcase Amdocs' ability to generate income relative to its revenue or operating costs. If, let's say, Amdocs is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Amdocs' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Amdocs' profitability requires more research than a typical breakdown of Amdocs' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.11 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.15 %, which entails that for every 100 dollars of revenue, it generated $0.15 of operating income.
Last ReportedProjected for 2024
Return On Capital Employed 0.15  0.14 
Return On Assets 0.08  0.06 
Return On Equity 0.14  0.07 

Management Efficiency

Amdocs has Return on Asset of 0.071 % which means that on every $100 spent on assets, it made $0.071 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1562 %, implying that it generated $0.1562 on every 100 dollars invested. Amdocs' management efficiency ratios could be used to measure how well Amdocs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.14 in 2024. Return On Assets is likely to drop to 0.06 in 2024. At this time, Amdocs' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 307 M in 2024, whereas Total Assets are likely to drop slightly above 4.5 B in 2024.
Last ReportedProjected for 2024
Price Book Value Ratio 2.54  1.38 
Enterprise Value Multiple 12.78  14.45 
Price Fair Value 2.54  1.38 
The analysis of Amdocs' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Amdocs' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Amdocs Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0213
Forward Dividend Yield
0.0213
Forward Dividend Rate
1.92
Beta
0.694

Technical Drivers

As of the 28th of March, Amdocs shows the mean deviation of 0.7534, and Risk Adjusted Performance of 0.0319. Amdocs technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Amdocs, which can be compared to its rivals. Please confirm Amdocs market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Amdocs is priced correctly, providing market reflects its regular price of 89.9 per share. Given that Amdocs has jensen alpha of (0.11), we suggest you to validate Amdocs's prevailing market performance to make sure the company can sustain itself at a future point.

Amdocs Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Amdocs middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Amdocs. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Amdocs Predictive Daily Indicators

Amdocs intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Amdocs stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Amdocs Corporate Filings

6K
20th of February 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
13A
13th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
9th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
6K
7th of February 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
5th of February 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
21st of December 2023
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
6K
14th of December 2023
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
13th of December 2023
Other Reports
ViewVerify

Amdocs Forecast Models

Amdocs' time-series forecasting models are one of many Amdocs' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amdocs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Amdocs Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Amdocs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amdocs shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Amdocs. By using and applying Amdocs Stock analysis, traders can create a robust methodology for identifying Amdocs entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin 0.12  0.11 
Operating Profit Margin 0.13  0.15 
Net Profit Margin 0.1  0.08 
Gross Profit Margin 0.35  0.41 

Current Amdocs Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amdocs analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Amdocs analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
108.0Strong Buy8Odds
Amdocs current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Amdocs analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Amdocs stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Amdocs, talking to its executives and customers, or listening to Amdocs conference calls.
Amdocs Analyst Advice Details

Amdocs Stock Analysis Indicators

Amdocs stock analysis indicators help investors evaluate how Amdocs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Amdocs shares will generate the highest return on investment. By understating and applying Amdocs stock analysis, traders can identify Amdocs position entry and exit signals to maximize returns.
Begin Period Cash Flow573.4 M
Long Term Debt645.7 M
Common Stock Shares Outstanding118.9 M
Total Stockholder Equity3.5 B
Tax Provision93.4 M
Quarterly Earnings Growth Y O Y0.18
Property Plant And Equipment Net951.9 M
Cash And Short Term Investments742.5 M
Cash520.1 M
Accounts Payable293.3 M
Net Debt287.2 M
50 Day M A91.5552
Total Current Liabilities1.4 B
Other Operating Expenses4.2 B
Non Current Assets Total4.5 B
Forward Price Earnings13.7741
Non Currrent Assets Other631.6 M
Stock Based Compensation89.7 M
When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.18
Dividend Share
1.74
Earnings Share
4.68
Revenue Per Share
41.665
Quarterly Revenue Growth
0.05
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.